News release

February 26, 2014


VANCOUVER, B.C. – PDC Biological Health Group Corporation is pleased to announce that it has been approved for listing on the Canadian Securities Exchange (“CSE”). The Company’s common shares will commence trading on the CSE at the opening of market on Thursday, February 27, 2014 under the symbol “PHG”.

About PDC

PDC’s primary product, the CRT 2000 Thermographic System, is a non-invasive, radiation-free, reproducible thermographic tool that measures the temperature of predetermined skin points and analyzes such data to provide a health care practitioner with information that may be indicative of irregular body function. The CRT 2000 Thermographic System is intended for use in preventive healthcare. The CRT 2000 Thermographic System is presently ready for sale; it has obtained the CE Safety Mark (TUV) the FDA premarket notification Class I (510(k)) and is certified as a Class II medical device by the Chinese health authority (SFDA).

For further information, please contact:
PDC Biological Health Group Corporation
Bernard Armani
Chief Executive Officer


The CSE does not accept responsibility for the adequacy or accuracy of this release.